Chemotherapeutic drugs targeting Her2 have exhibited a sensitivity ranking in breast cancer cell lines as follows: SKBR3>MDA‐MB‐468>MCF7>MDA‐MB‐231.27 The gene discussed is ERBB2; the disease is breast cancer.